ProCE Banner Activity

Meeting Individuals Where They Are: A Conversation on Breaking Down Barriers to HCV Screening and Care for London’s Pakistani Community

Clinical Thought
The stigma surrounding HCV infection creates a barrier that often seems impenetrable, especially when fortified by language and cultural differences. Here we discuss ways to reach the other side of the barrier to better engage individuals in care.

Released: June 14, 2021

Expiration: June 13, 2022

Share

Faculty

Shabana Begum

Shabana Begum

South Asian Projects Officer
The Hepatitis C Trust
COVID-19 Community Champions Lead
Karmand Community Centre, Bradford & Empower ladies CIC, Kirklees
Director, Empower Ladies CIC
Huddersfield, United Kingdom

Graham R. Foster

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Partners

AHF

ProCE Banner

BAI

ProCE Banner

Hep C Trust

ProCE Banner

IAS 2021

ProCE Banner

Faculty Disclosure

Primary Author

Shabana Begum,

South Asian Projects Officer
The Hepatitis C Trust
COVID-19 Community Champions Lead
Karmand Community Centre, Bradford & Empower ladies CIC, Kirklees
Director, Empower Ladies CIC
Huddersfield, United Kingdom

Shabana Begum has disclosed that she has received consulting fees from Gilead Sciences.

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Graham R. Foster, FRCP, PhD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, GlaxoSmithKline, Merck, and Roche and has ownership interest in GlaxoSmithKline.